ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer.

Kunal B Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.